Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses

Autor: Li, Xueqi, Edén, Arvid, Malwade, Susmita, Cunningham, Janet L., Bergquist, Jonas, Weidenfors, Jacob Ahlberg, Sellgren, Carl M., Engberg, Göran, Piehl, Fredrik, Gisslen, Magnus, Kumlien, Eva, Virhammar, Johan, Orhan, Funda, Rostami, Elham, Schwieler, Lilly, Erhardt, Sophie

Publikováno v: In Brain Behavior and Immunity February 2025 124:163-176

Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.

Autor: Li X; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Edén A; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41685, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Disease, Gothenburg, 41685, Sweden., Malwade S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Cunningham JL; Department of Medical Science, Psychiatry, Uppsala University, Uppsala 75185, Sweden; Department of Neuroscience, Karolinska Institute, Stockholm 17177, Sweden., Bergquist J; Analytical Chemistry and Neurochemistry, Department of Chemistry─BMC, Uppsala University, Box 599, 751 24 Uppsala, Sweden; The ME/CFS Collaborative Research Centre at Uppsala University, 751 24 Uppsala, Sweden., Weidenfors JA; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Sellgren CM; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden., Engberg G; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden; Institute of Sport Science and Innovations, Lithuanian Sports University, Kaunas, Lithuania., Piehl F; Unit of Neuroimmunology, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm 17177, Sweden; Division of Neurology, Karolinska University Hospital, Stockholm 17176, Sweden., Gisslen M; Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 41685, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Infectious Disease, Gothenburg, 41685, Sweden; Public Health Agency of Sweden, Solna, Sweden., Kumlien E; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Virhammar J; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Orhan F; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Rostami E; Department of Neuroscience, Karolinska Institute, Stockholm 17177, Sweden; Department of Medical Sciences, Neurology, Uppsala University, Uppsala 75185, Sweden., Schwieler L; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden., Erhardt S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: sophie.erhardt@ki.se.

Publikováno v: Brain, behavior, and immunity [Brain Behav Immun] 2024 Nov 29; Vol. 124, pp. 163-176. Date of Electronic Publication: 2024 Nov 29.